Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.
Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, Hepner A, Kaye R; Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators.
Pioro EP, et al.
Ann Neurol. 2010 Nov;68(5):693-702. doi: 10.1002/ana.22093.
Ann Neurol. 2010.
PMID: 20839238
Clinical Trial.